- All sections
- C - Chemistry; metallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
- C12Q 1/6827 - Hybridisation assays for detection of mutation or polymorphism
Patent holdings for IPC class C12Q 1/6827
Total number of patents in this class: 2235
10-year publication summary
51
|
83
|
91
|
223
|
328
|
335
|
304
|
259
|
270
|
201
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Natera, Inc. | 270 |
51 |
Guardant Health, Inc. | 346 |
44 |
Illumina, Inc. | 2932 |
36 |
Bio-Rad Laboratories, Inc. | 1602 |
34 |
10X Genomics, Inc. | 1018 |
31 |
The Chinese University of Hong Kong | 148 |
30 |
Regeneron Pharmaceuticals, Inc. | 3825 |
26 |
The Regents of the University of California | 19182 |
25 |
The Broad Institute, Inc. | 1638 |
25 |
Massachusetts Institute of Technology | 9837 |
24 |
Foundation Medicine, Inc. | 276 |
23 |
Children's Medical Center Corporation | 1791 |
21 |
The Johns Hopkins University | 5428 |
20 |
President and Fellows of Harvard College | 5838 |
19 |
Exact Sciences Corporation | 277 |
19 |
Affymetrix, Inc. | 264 |
18 |
Grail, LLC | 205 |
18 |
Roche Molecular Systems, Inc. | 895 |
17 |
The Chinese University of Hong Kong | 630 |
16 |
Pacific Biosciences of California, Inc. | 747 |
16 |
Other owners | 1722 |